Insider trades
Scott T. Rottinghaus, Chief Officer of Enanta Pharmaceuticals ENTA, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $11.4K. The latest trade was on 02/12.
Scott T. Rottinghaus
Chief Medical Officer
- Company
- Enanta Pharmaceuticals ENTA
- First filing
- 23/11/22
- Trades
- 21 trades
- Buys / sales
- 0 / 6
- 12-month net buying
- −$11.4K
- Last trade
- 02/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/12/05 | 25/12/05 | 798 sh | $14.23 | $11,355.54 | −3.5% | |
| Open-market sale10b5-1 plan | 24/12/06 | 24/12/10 | 866 sh | $8.06 | $6,979.96 | −4.6% | |
ENTA | Open-market sale10b5-1 plan | 24/07/11–24/07/15 | 24/07/15 | 11,945 sh3 trades | $15.97avg. | $190,746.77 | −35.5% |
| Open-market sale | 23/12/05 | 23/12/06 | 534 sh | $9.63 | $5,142.42 | −2.0% |